ΔF508 heterozygosity in cystic fibrosis and susceptibility to asthma

This publication has 19 references indexed in Scilit:

• A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.
  Journal of Clinical Investigation, 1997
• Genetic risk factors for chronic obstructive pulmonary disease
  European Respiratory Journal, 1997
• A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
  Journal of Clinical Investigation, 1997
• Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis
  Nature Medicine, 1995
• Genetic analysis of cystic fibrosis in Denmark. Implications for genetic counselling, carrier diagnosis and prenatal diagnosis
  Acta Paediatrica, 1992
• Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis.
  Thorax, 1987
• Bronchial hyperreactivity in cystic fibrosis and asthma
  The Journal of Pediatrics, 1978
• Prevalence of atopy and exercise-induced bronchial lability in relatives of patients with cystic fibrosis.
  Archives of Disease in Childhood, 1975
• THE PREVALENCE OF RESPIRATORY DISEASE IN HETEROZYGOTES FOR THE GENE FOR FIBROCYSTIC DISEASE OF THE PANCREAS
  The Lancet, 1963
• Anamnesis, Sweat Electrolyte and Pulmonary Function Studies in Parents of Patients with Cystic Fibrosis of the Pancreas1
  Acta Paediatrica, 1963